Assessment of Quality of Life in lower limb arteriopathy (Artemis)

Lecasble M


Basic description

Mesure de la Qualité de Vie dans Artériopathie des membres inférieurs


Lecasble M

© New England Medical Center Hospitals, Inc.S.E. Berki, The University of Michigan, School of Public Health MAPI SA
To assess the effect of Intermittent Claudication on Patients’ Quality of Life
Therapeutic area
  • Cardiovascular Diseases
  • Pathological Conditions, Signs and Symptoms
Therapeutic indication

Intermittent Claudication

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • French for France
Bibliographic reference(s) of the original questionnaire

Marquis P. (Evaluation of the impact of peripheral obliterative arteriopathy on quality of life) [In French] Evaluation de l'Impact de l'Artériopathie Oblitérante des Membres Inférieurs sur la Qualité de Vie. Drugs 1998; 56(Suppl. 3):25-35

Marquis P, Lecasble M, Passa Ph. (Quality of Life in Patients with PAOD treated with Ifenprodil Tartrate: Results of the ARTEMIS Study) [In French] Qualité de vie de patients souffrant d'AOMI traités par le tartrate d'ifenprodil. Résultats de l'étude ARTEMIS. Drugs 1998; 56(Suppl. 3):37-48 

Development and Validation of a Disease specific Short Form Quality of Life Questionnaire in Intermittent Claudication (Abstract). Quality of Life Research 1995;4(5):458

Marquis P, Fayol C, McCarthy C, et al. Quality of Life Assessment in Patients with Intermittent Claudication: Clinical Evaluation of a Questionnaire. La Presse Medicale.1994;23(28):1288–1292

Marquis P, Fayol C, McCarthy C et al. [In French] Mesure de la Qualité de Vie Dans la Claudication Intermittente: Validation Clinique d'un Questionnaire. Journal des Maladies Vasculaires 1994;19(suppl. B):237

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us